Pharmacokinetics in Subjects With Renal Impairment

NCT01504165 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Impairment

Interventions

DRUG: cilengitide 2000mg
DRUG: cilengitide 2000mg
DRUG: cilengitide 2000mg
DRUG: cilengitide 1000mg
DRUG: cilengitide > 1000mg and up to 2000mg

Sponsor

Merck KGaA, Darmstadt, Germany